Esperion Therapeutics Inc Net Asset Quality Index
Esperion Therapeutics Inc net asset quality index. Esperion Therapeutics Inc (ESPR) has a Net Asset Quality Index of -124.0% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $364.02 Million minus total liabilities of $815.38 Million yields net assets of $-451.36 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Esperion Therapeutics Inc's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Esperion Therapeutics Inc (1999–2024)
Net asset quality index of Esperion Therapeutics Inc from 1999 to 2024. This chart shows how Esperion Therapeutics Inc's Net Asset Quality Index has evolved across 18 annual periods from 1999 to 2024. As of September 2025, the index stands at -124.0%, representing net assets of $-451.36 Million against total assets of $364.02 Million USD. Check Esperion Therapeutics Inc (ESPR) strategic asset index to assess the company's strategic physical and investment asset allocation.
Esperion Therapeutics Inc Net Asset Quality Index by Year (1999–2024)
Esperion Therapeutics Inc net asset quality index by year from 1999 to 2024. The table below presents the year-by-year Net Asset Quality Index for Esperion Therapeutics Inc from 1999 to 2024, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Esperion Therapeutics Inc market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -113.1% | $-388.72 Million | $343.82 Million | $732.54 Million | ▲ +108.0 pp |
| 2023 | -221.1% | $-454.99 Million | $205.80 Million | $660.79 Million | ▼ -90.5 pp |
| 2022 | -130.6% | $-323.78 Million | $247.94 Million | $571.72 Million | ▼ -79.0 pp |
| 2021 | -51.6% | $-196.94 Million | $381.59 Million | $578.53 Million | ▼ -24.4 pp |
| 2020 | -27.2% | $-96.13 Million | $353.26 Million | $449.39 Million | ▼ -36.5 pp |
| 2019 | 9.3% | $19.95 Million | $214.45 Million | $194.50 Million | ▼ -45.9 pp |
| 2018 | 55.2% | $79.12 Million | $143.45 Million | $64.33 Million | ▼ -32.9 pp |
| 2017 | 88.1% | $244.69 Million | $277.83 Million | $33.14 Million | ▼ -5.2 pp |
| 2016 | 93.2% | $228.60 Million | $245.21 Million | $16.61 Million | ▼ -4.0 pp |
| 2015 | 97.2% | $287.26 Million | $295.57 Million | $8.31 Million | ▲ +4.0 pp |
| 2014 | 93.2% | $133.55 Million | $143.34 Million | $9.79 Million | ▼ -1.5 pp |
| 2013 | 94.6% | $74.09 Million | $78.29 Million | $4.20 Million | ▲ +332.4 pp |
| 2012 | -237.8% | $-17.39 Million | $7.31 Million | $24.70 Million | ▲ +40.1 pp |
| 2011 | -277.9% | $-6.06 Million | $2.18 Million | $8.24 Million | ▼ -353.2 pp |
| 2002 | 75.4% | $38.74 Million | $51.41 Million | $12.66 Million | ▼ -9.5 pp |
| 2001 | 84.9% | $66.50 Million | $78.34 Million | $11.84 Million | ▼ -2.0 pp |
| 2000 | 86.9% | $67.69 Million | $77.88 Million | $10.19 Million | ▲ +51.7 pp |
| 1999 | 35.2% | $2.81 Million | $8.00 Million | $5.18 Million | — |